Posted on 9月 17, 20199/17/19
Are We Transforming In The Right Way?
Posted on 8月 13, 20198/13/19
European Pricing Platform: The State of International Reference Pricing
Posted on 6月 15, 20196/15/19
Sell’N Gene Therapies: A Landscape Assessment Of Cell And Gene Therapy Reimbursement
Posted on 5月 13, 20195/13/19
Will the U.S. adopt global reference pricing?
Posted on 4月 25, 20194/25/19
New start versus switch patients for biosimilars?
Posted on 4月 25, 20194/25/19
Care pathways—do you know where your biosimilars are used?
Posted on 4月 25, 20194/25/19
Is your biosimilar product on the payer radar?
Posted on 4月 9, 20194/9/19
“Who wants the biggest slice of the biosimilar pie?”: The Humira biosimilar wave in Europe
Posted on 4月 9, 20194/9/19
Precision Medicine Meets Precision Patient Support
Posted on 1月 10, 20171/10/17